Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10‐Year Cohort

Publisher: John Wiley & Sons Inc

E-ISSN: 2047-9980|5|1|JAHA.115.002584-JAHA.115.002584

ISSN: 2047-9980

Source: JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol.5, Iss.1, 2016-01, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content